150 related articles for article (PubMed ID: 19224502)
1. [The role of bone metabolic markers in qualification for treatment of osteoporosis. Results of POMOST study].
Przedlacki J; Bartoszewicz Z; Ksiezopolska-Orłowska K; Kondracka A; Grodzki A; Bartuszek T; Bartuszek D; Swirski A; Loth E; Musiał J; Luczak E; Teter P; Lasiewicki A; Walkiewicz A; Drozdowska-Rusinowicz I
Endokrynol Pol; 2009; 60(1):25-32. PubMed ID: 19224502
[TBL] [Abstract][Full Text] [Related]
2. Bone turnover: Biology and assessment tools.
Szulc P
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):725-738. PubMed ID: 30449551
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
[TBL] [Abstract][Full Text] [Related]
4. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
[TBL] [Abstract][Full Text] [Related]
5. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
[TBL] [Abstract][Full Text] [Related]
7. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.
Chubb SA; Byrnes E; Manning L; Beilby JP; Ebeling PR; Vasikaran SD; Golledge J; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2015 Jan; 100(1):90-9. PubMed ID: 25322270
[TBL] [Abstract][Full Text] [Related]
8. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women.
Ivaska KK; Gerdhem P; Akesson K; Garnero P; Obrant KJ
J Bone Miner Res; 2007 Aug; 22(8):1155-64. PubMed ID: 17488197
[TBL] [Abstract][Full Text] [Related]
9. [Significance of Bone Turnover Marker Measurement in the Treatment of Osteoporosis].
Miura M; Satoh Y
Yakugaku Zasshi; 2019; 139(1):27-33. PubMed ID: 30606924
[TBL] [Abstract][Full Text] [Related]
10. Critical points in strategies for the diagnosis and treatment of osteoporosis.
Lorenc RS; Misiorowski W; Karczmarewicz E
Endokrynol Pol; 2009; 60(2):124-33. PubMed ID: 19396756
[TBL] [Abstract][Full Text] [Related]
11. High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study.
Szulc P; Montella A; Delmas PD
Ann Rheum Dis; 2008 Sep; 67(9):1249-55. PubMed ID: 18065499
[TBL] [Abstract][Full Text] [Related]
12. The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
Anagnostis P; Vyzantiadis TA; Charizopoulou M; Adamidou F; Karras S; Goulis DG; Karagiannis A; Garipidou V; Vakalopoulou S
Thromb Haemost; 2013 Aug; 110(2):257-63. PubMed ID: 23740140
[TBL] [Abstract][Full Text] [Related]
13. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.
Bauer DC; Black DM; Garnero P; Hochberg M; Ott S; Orloff J; Thompson DE; Ewing SK; Delmas PD;
J Bone Miner Res; 2004 Aug; 19(8):1250-8. PubMed ID: 15231011
[TBL] [Abstract][Full Text] [Related]
14. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
16. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
[TBL] [Abstract][Full Text] [Related]
17. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone metabolism and prediction of fracture in elderly women.
Gerdhem P; Ivaska KK; Alatalo SL; Halleen JM; Hellman J; Isaksson A; Pettersson K; Väänänen HK; Akesson K; Obrant KJ
J Bone Miner Res; 2004 Mar; 19(3):386-93. PubMed ID: 15040826
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of bone turnover marker concentrations in osteoporosis.
Morris HA; Eastell R; Jorgensen NR; Cavalier E; Vasikaran S; Chubb SAP; Kanis JA; Cooper C; Makris K;
Clin Chim Acta; 2017 Apr; 467():34-41. PubMed ID: 27374301
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.
Szulc P; Delmas PD
Osteoporos Int; 2008 Dec; 19(12):1683-704. PubMed ID: 18629570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
